FDA-approved drug promotes remyelination
Crossref DOI link: https://doi.org/10.1038/s41582-022-00729-3
Published Online: 2022-09-23
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lempriere, Sarah
Text and Data Mining valid from 2022-09-23
Version of Record valid from 2022-09-23
Article History
First Online: 23 September 2022